Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Ritonavir 80 mg/mL in 90 mL, 225 mL Solution, oral Abbott Laboratories, Chemical & Agricultural Products Division, North Chicago, Illinois, United States of America and Abbott Laboratories Limited, Queenborough, Kent, England Norvir Ritonavir 100 mg Capsule Abbott Laboratories, Chemical & Agricultural Products Division, North Chicago, Illinois, United States of America and Abbott Laboratories Limited, Queenborough, Kent, England Norvir [tn1,4] Note: This consent is valid for 2 years from the date of publication of this notice. Dated this 25th day of January 1997. KAREN O. POUTASI (Dr), Director-General of Health, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.